Screener
Bioventus BVS Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Bioventus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Income tax (benefit) expense, net | (20,897) | 1,041 | (20,326) | 946 |
| Net income | 36,205 | 9,272 | 40,151 | 5,950 |
| Income attributable to noncontrolling interest | (2,764) | (1,813) | (3,597) | (1,128) |
| Net income attributable to Bioventus Inc. | $33,441 | $7,459 | $36,554 | $4,822 |
| Net income | $36,205 | $9,272 | $40,151 | $5,950 |
| Other comprehensive income (loss), net of tax | ||||
| Change in foreign currency translation adjustments | 243 | 1,593 | (1,225) | 2,226 |
| Change in the fair value of cash flow hedges | 928 | — | 1,928 | — |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bioventus's net income?
- Bioventus (BVS) reported net income of $33.44M in Q2 2026.
- How has Bioventus's net income changed year-over-year?
- Bioventus's net income increased by 348.3% year-over-year, from $7.46M to $33.44M.
- What is the long-term trend for Bioventus's net income?
- Over 4 years (2021 to 2025), Bioventus's net income has grown at a 14.7% compound annual growth rate (CAGR), from $13.14M to $22.73M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Bioventus's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude